Epitope Studies with Anti-β2-glycoprotein I Antibodies from Autoantibody and Immunized Sources

This publication has 17 references indexed in Scilit:

• Modification of β₂glycoprotein I by Glutardialdehyde: Conformational Changes and Aggregation Accompany Exposure of the Cryptic Autoepitope
  Applied Biochemistry and Biotechnology, 1999
• Anti-β2 glycoprotein I (β2GPI) autoantibodies recognize an epitope on the first domain of β2GPI
  Proceedings of the National Academy of Sciences, 1998
• Current Insights into the “Antiphospholipid” Syndrome: Clinical, Immunological, and Molecular Aspects
  Published by Elsevier ,1998
• Role of Divalency in the High-Affinity Binding of Anticardiolipin Antibody−β₂-Glycoprotein I Complexes to Lipid Membranes
  Biochemistry, 1996
• Anti β2 glycoprotein I antibodies: detection and association with thrombosis
  British Journal of Haematology, 1995
• Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.
  The Journal of Experimental Medicine, 1994
• Some ‘antiphospholipid antibodies’ bind to β₂‐glycoprotein I in the absence of phospholipid
  British Journal of Haematology, 1992
• Immunology and Clinical Importance of Antiphospholipid Antibodies
  Published by Elsevier ,1991
• Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
  Proceedings of the National Academy of Sciences, 1990
• Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
  The Lancet, 1990